Supply Chain Council of European Union | Scceu.org
Distribution

Dept failed to do quality tests before labour drugs distribution

REPORTS BY GRACE AUKA-SALMANG

The Health Department failed to do a quality test of Misoprostol, a drug that helps induce labour for pregnant women and was distributed throughout Morobe Province in 2014, according to the Parliamentary Public Accounts Committee.
When asked by the committee to confirm if this is was true, Health Department’s Pharmaceutical Services Standard branch manager Vali Karo said at that time, he was not the manager and could not confirm whether this medicines were rechecked or destroyed.
Mr Karo said this during the fifth session of the inquiry into the procurement and supply of medicine and medical kits worth more than K100 million to Borneo Pacific Pharmaceutical Limited (BPPL) this year.
He, however, recalled that all the medicines and medical drugs had passed the test except for this particular drug Misoprostol.
According to the inquiry, the logistics company responsible for the distribution of these drugs had by then delivered these medicines in Morobe Province.
This was confirmed by a letter written by the company to the Health Department telling them the medicines had already being delivered and the drugs were brought in by the major supplier BPPL.
PAC deputy chairman Garry Juffa raised concerns why these drugs were not tested and asked Mr Karo to explain why these medicines were not destroyed immediately before distribution, adding that these could have already killed some of the innocent mothers and babies.
Mr Karo, could not confirm this statement saying he would check his records and report back to PAC today because at the time when this issue arose, PNG never had a testing lab for medicines that are brought in. As a pharmacist, he said, when a drug is manufactured, how good the quality of the medicine is determined by the various tests that are done and is part of the certificate of analysis.
“This is a quality document that is issued by the quality department of the manufacturer so as part of the certificate of analysis, there are various tests that are done and one of them is the presence of the active ingredient through various instrumentation that will tell whether that active ingredient is present in the medicine. The other is the uniformative content and the dissolution or whether that drug will dissolve given the time.”

Related posts

Jefferson County man Enrico Fionn Hernandez sentenced for heroin and fentanyl distribution • STL.News

scceu

Firecracker traders see red over green Diwali- The New Indian Express

scceu

Wisconsin nursing homes finalizing vaccine distribution plans

scceu